| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/11/2009 | CN101380363A Medicine composition for preventing the birth defect and improving the memory |
| 03/11/2009 | CN101380352A Medicine composition for preventing the birth defect and improving the memory |
| 03/11/2009 | CN101380351A Medicine composition for preventing the birth defect and improving the memory |
| 03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 03/11/2009 | CN101380181A Tea-leaf health-care pillow core with rose fragrant |
| 03/11/2009 | CN101380112A Medicine composition for preventing the birth defect and improving the memory |
| 03/11/2009 | CN101380050A Drunkenness dispelling tea |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467476C Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467468C Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders |
| 03/11/2009 | CN100467464C Long-chain aromatic piperazine modified duloxetine-like compound, and its preparation and use |
| 03/11/2009 | CN100467458C Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2009 | CN100467449C Cyclic aminophenyl sulfamate derivative |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
| 03/11/2009 | CN100467038C Biological and pharmacological effects and preparation process of liver protecting preparation containing vitamins |
| 03/11/2009 | CN100467023C Use of N-(3-methoxy-5-methyl pyrazine-2-group)-2-(4-[1,3,4-oxadiazole-2-group]phenyl) pyridine-3-sulfanilamide as anticarcinogen |
| 03/11/2009 | CN100467017C Effervescence tablet of Chinese magnoliavine fruit and its preparation process |
| 03/11/2009 | CA2638354A1 Association of an anti-atherothrombotic and an angiotensin converting enzyme inhibitor |
| 03/10/2009 | US7501525 Derivatives of benzimidazole and their use as medicaments |
| 03/10/2009 | US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 03/10/2009 | US7501431 Physiologically active substances PF1270A, B and C substances |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501130 Methods for treating myofascial pain |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | CA2468649C Adenosine a2a receptor antagonists |
| 03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
| 03/10/2009 | CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 03/10/2009 | CA2345069C 2-phenylpyran-4-one derivatives |
| 03/10/2009 | CA2285263C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/10/2009 | CA2197677C A method of selectively destroying neoplastic cells |
| 03/05/2009 | WO2009029609A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 03/05/2009 | WO2009029439A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 03/05/2009 | WO2009029252A1 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/05/2009 | WO2009029214A1 Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| 03/05/2009 | WO2009028605A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 03/05/2009 | WO2009028588A1 Polycyclic compound |
| 03/05/2009 | WO2009027820A2 Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| 03/05/2009 | WO2009027766A2 New crystalline solid forms of o-desvenlafaxine base |
| 03/05/2009 | WO2009027753A1 Composition and method inhibiting inflammation |
| 03/05/2009 | WO2009027705A1 Pharmaceutical powder compositions comprising a benzodiazepine drug and chitosan |
| 03/05/2009 | WO2009027577A1 A combination treatment |
| 03/05/2009 | WO2009027564A1 Use and methods of use for an antagonist of the serotin3 receptor (5-ht3) and a selective modulator of chloride channels for the treatment of addiction to or dependence on medicines/drugs or nervous system disorders |
| 03/05/2009 | WO2009027437A1 Liquid formulation of g-csf conjugate |
| 03/05/2009 | WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
| 03/05/2009 | WO2009027350A1 Use of sco-spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands |
| 03/05/2009 | WO2009027349A2 Treatment and prevention of neurodegenerative diseases |
| 03/05/2009 | WO2009027295A1 3-azabicyclo (4.1.0) heptane derivatives useful as norepinephrine, serotonin or dopamine reuptake inhibitors |
| 03/05/2009 | WO2009027294A1 Substituted azabicyclo [4.1.0] heptane compounds for use as monoamine reuptake inhibitors |
| 03/05/2009 | WO2009027293A1 Compounds |
| 03/05/2009 | WO2009027292A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
| 03/05/2009 | WO2009027105A2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders |
| 03/05/2009 | WO2009027086A2 Use of vitex agnus castus extracts for preparing a medicament |
| 03/05/2009 | WO2009026935A1 Catecholamine derivatives and prodrugs thereof |
| 03/05/2009 | WO2009026934A1 Catecholamine derivatives useful for the treatment of parkinson' s disease |
| 03/05/2009 | WO2009026687A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 03/05/2009 | WO2009026658A1 Ppar agonists |
| 03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
| 03/05/2009 | WO2009026653A1 Neuroplasticity assay |
| 03/05/2009 | WO2009026621A1 Pharmaceutical compound & composition |
| 03/05/2009 | WO2009012242A3 Sodium channel inhibitors |
| 03/05/2009 | WO2009010454A3 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 03/05/2009 | WO2009001356A3 Acyl-urea derivatives and uses thereof |
| 03/05/2009 | WO2008142463A3 Carbamoyl-cyclohexanes for treating acute mania |
| 03/05/2009 | WO2008139263A3 Methods for slowing the progression of multiple sclerosis |
| 03/05/2009 | WO2008131411A3 Stimulating neuronal growth using brevetoxins |
| 03/05/2009 | WO2008108322A3 Composition and method for protecting mitochondria |
| 03/05/2009 | WO2008097536A3 Compositions and methods for treating psychiatric diseases and disorders |
| 03/05/2009 | WO2008086483A3 Modulation of neurogenesis with use of modafinil |
| 03/05/2009 | WO2008024893A3 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 03/05/2009 | WO2008023258A8 Piperidine derivatives |
| 03/05/2009 | WO2008010073A8 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine |
| 03/05/2009 | US20090064353 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines |
| 03/05/2009 | US20090062403 Compositions and Methods for Treatment of Disorders of Protein Aggregation |
| 03/05/2009 | US20090062401 Decaline-derived compounds as pharmaceutically active agents |
| 03/05/2009 | US20090062392 Deuterium-enriched gabapentin |
| 03/05/2009 | US20090062388 Use of acetyl L-carnitine for the preparation of a medication for the preventive therapy for pain |
| 03/05/2009 | US20090062383 Salts of Substituted Allophanates and Their Use in Drugs |
| 03/05/2009 | US20090062367 Deuterium-enriched eletriptan |
| 03/05/2009 | US20090062356 Substituted benzimidazole derivatives |
| 03/05/2009 | US20090062354 Method of increasing the extent of absorption of tizanidine |
| 03/05/2009 | US20090062336 Methods of Diminishing Co-Abuse Potential |
| 03/05/2009 | US20090062324 Catecholamine derivatives and prodrugs thereof |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062321 Hydroxybenzoate Salts Of Metanicotine Compounds |
| 03/05/2009 | US20090062312 Deuterium-enriched indiplon |
| 03/05/2009 | US20090062304 Benzimidazole derivatives and their use for modulating the gaba-alpha receptor complex |
| 03/05/2009 | US20090062303 Deuterium-enriched ziprasidone |
| 03/05/2009 | US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 03/05/2009 | US20090062293 1,4-Substituted Piperazine Derivatives |
| 03/05/2009 | US20090062290 Heterocycles as potassium channel modulators |
| 03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
| 03/05/2009 | US20090062282 Substituted Amino-Pyrimidones and Uses Thereof |
| 03/05/2009 | US20090062260 Compounds and compositions as lxr modulators |